| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 328 | 680 | 1,088 | 1,098 | | Cost of Revenue | 374 | 372 | 491 | 299 | | | Gross Profit | (46) | 308 | 597 | 799 | | | Operating Expenses | | Research Development | 17,670 | 11,638 | 12,763 | 17,726 | | Selling General and Administrative | 8,538 | 7,397 | 9,468 | 8,273 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (26,254) | (18,727) | (21,634) | (25,200) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 12,314 | (36,082) | (315) | (491) | | Earnings Before Interest And Taxes | (13,940) | (54,809) | (21,949) | (25,691) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (13,940) | (54,809) | (21,949) | (25,691) | | Income Tax Expense | (64) |
-
|
-
| (1,344) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (13,876) | (54,809) | (21,949) | (24,347) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 142 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (13,876) | (54,809) | (21,949) | (24,205) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($13,876) | ($54,809) | ($21,949) | ($24,205) |
|
0.50% Nasdaq 
Income Statement
